A detailed history of Blue Water Life Science Advisors, LP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 230,000 shares of TXG stock, worth $3.76 Million. This represents 4.35% of its overall portfolio holdings.

Number of Shares
230,000
Previous 194,500 18.25%
Holding current value
$3.76 Million
Previous $7.3 Million 38.72%
% of portfolio
4.35%
Previous 6.87%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$19.45 - $37.37 $690,475 - $1.33 Million
35,500 Added 18.25%
230,000 $4.47 Million
Q4 2023

Feb 14, 2024

BUY
$34.32 - $57.55 $6.68 Million - $11.2 Million
194,500 New
194,500 $10.9 Million
Q2 2022

Aug 15, 2022

SELL
$36.95 - $82.41 $7.83 Million - $17.5 Million
-211,917 Closed
0 $0
Q1 2022

May 18, 2022

BUY
$55.7 - $145.79 $11.8 Million - $30.9 Million
211,917 New
211,917 $16.1 Million

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.55B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Blue Water Life Science Advisors, LP Portfolio

Follow Blue Water Life Science Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Water Life Science Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Blue Water Life Science Advisors, LP with notifications on news.